{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:14:03Z","timestamp":1761718443429},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12872-015-0164-4","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T21:36:41Z","timestamp":1450388201000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Myocardial infarction, symptomatic third degree atrioventricular block and pulmonary embolism caused by thalidomide: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Shengyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"key":"164_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/2042098612452291","volume":"3","author":"A Palumbo","year":"2012","unstructured":"Palumbo A, Palladino C. Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance. Ther Adv Drug Saf. 2012;3:255\u201366.","journal-title":"Ther Adv Drug Saf"},{"key":"164_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000348367","volume":"125","author":"A Ali","year":"2013","unstructured":"Ali A, Hothi SS, Thompson A, Malik N. Negative chronotropic effects and coronary ischaemic abnormalities following thalidomide therapy. Cardiology. 2013;125:34\u20137.","journal-title":"Cardiology"},{"key":"164_CR3","first-page":"424","volume":"58","author":"I Lopez-de la Cruz","year":"2006","unstructured":"Lopez-de la Cruz I, Aguayo-Gonzalez A, Lopez-Karpovitch X. Thalidomide-associated bradycardia in patients with hematologic diseases: a single institution experience. Rev Invest Clin. 2006;58:424\u201331.","journal-title":"Rev Invest Clin"},{"key":"164_CR4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.amjcard.2003.12.061","volume":"93","author":"IE Fahdi","year":"2004","unstructured":"Fahdi IE, Gaddam V, Saucedo JF, Kishan CV, Vyas K, Deneke MG, et al. Bradycardia during therapy for multiple myeloma with thalidomide. Am J Cardiol. 2004;93:1052\u20135.","journal-title":"Am J Cardiol"},{"key":"164_CR5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00392-006-0401-z","volume":"95","author":"M Hinterseer","year":"2006","unstructured":"Hinterseer M, Becker A, Kaab S, Lang N, Nabauer M, Steinbeck G. Thalidomide-induced symptomatic third-degree atrioventricular block. Clin Res Cardiol. 2006;95:474\u20136.","journal-title":"Clin Res Cardiol"},{"key":"164_CR6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(03)80085-1","volume":"25","author":"SJ Matthews","year":"2003","unstructured":"Matthews SJ, McCoy C. Thalidomide: a review of approved and investigational uses. Clin Ther. 2003;25:342\u201395.","journal-title":"Clin Ther"},{"key":"164_CR7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00277-004-0891-6","volume":"83","author":"A Corso","year":"2004","unstructured":"Corso A, Lorenzi A, Terulla V, Airo F, Varettoni M, Mangiacavalli S, et al. Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone. Ann Hematol. 2004;83:588\u201391.","journal-title":"Ann Hematol"},{"key":"164_CR8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1538-7836.2003.00083.x","volume":"1","author":"MC Minnema","year":"2003","unstructured":"Minnema MC, Fijnheer R, De Groot PG, Lokhorst HM. Extremely high levels of von willebrand factor antigen and of procoagulant factor viii found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. J Thromb Haemost. 2003;1:445\u20139.","journal-title":"J Thromb Haemost"},{"key":"164_CR9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2796.2007.01788.x","volume":"261","author":"I Kardasz","year":"2007","unstructured":"Kardasz I, De Caterina R. Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update. J Intern Med. 2007;261:330\u201348.","journal-title":"J Intern Med"},{"key":"164_CR10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4330\/wjc.v6.i7.602","volume":"6","author":"K Komamura","year":"2014","unstructured":"Komamura K, Fukui M, Iwasaku T, Hirotani S, Masuyama T. Takotsubo cardiomyopathy: pathophysiology, diagnosis and treatment. World J Cardiol. 2014;6:602\u20139.","journal-title":"World J Cardiol"},{"key":"164_CR11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijcard.2014.11.186","volume":"180","author":"G Novo","year":"2015","unstructured":"Novo G, Giambanco S, Bonomo V, Sutera MR, Giambanco F, Rotolo A, et al. Troponin i\/ejection fraction ratio: a new index to differentiate takotsubo cardiomyopathy from myocardial infarction. Int J Cardiol. 2015;180:255\u20137.","journal-title":"Int J Cardiol"},{"key":"164_CR12","first-page":"277","volume":"306","author":"I Eitel","year":"2011","unstructured":"Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011;306:277\u201386.","journal-title":"JAMA"},{"key":"164_CR13","first-page":"138","volume":"4","author":"AA Kohan","year":"2014","unstructured":"Kohan AA, Levy Yeyati E, De Stefano L, Dragonetti L, Pietrani M, Perez de Arenaza D, et al. Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature. Cardiovasc Diagn Ther. 2014;4:138\u201346.","journal-title":"Cardiovasc Diagn Ther"},{"key":"164_CR14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jth.12070","volume":"11","author":"D Farge","year":"2013","unstructured":"Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11:56\u201370.","journal-title":"J Thromb Haemost"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0164-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T21:58:41Z","timestamp":1498255121000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2261\/15\/173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1186\/s12872-015-0164-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"173"}}